SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹63 Cr | ₹0.58 Cr | ₹-2.45 Cr | ₹0.83 Cr | ₹-1.08 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹63 Cr |
Mar2023 | ₹0.58 Cr |
Mar2022 | ₹-2.45 Cr |
Mar2017 | ₹0.83 Cr |
Mar2016 | ₹-1.08 Cr |
How is Net Cash Inflow / Outflow of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹63 Cr | 10,713.84 | |
Mar2023 | ₹0.58 Cr | Positive | |
Mar2022 | ₹-2.45 Cr | Negative | |
Mar2017 | ₹0.83 Cr | Positive | |
Mar2016 | ₹-1.08 Cr | - |
Compare Net Cash Inflow / Outflow of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,802.0 Cr | -10% | -2.7% | 48.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,249.0 Cr | -1.3% | -3.3% | 8.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,940.0 Cr | -1.5% | 0.8% | 42.3% | Stock Analytics | |
CIPLA | ₹121,197.0 Cr | -1.7% | 2.3% | -5.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,618.0 Cr | -1.6% | 8.4% | 10.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,250.0 Cr | -3.3% | -1.4% | 9.8% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -10% |
-2.7% |
48.3% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses